Patient Square Capital
Latest statistics and disclosures from Patient Square Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ROIV, RVMD, MIRM, ABVX, ONC, and represent 64.94% of Patient Square Capital's stock portfolio.
- Added to shares of these 10 stocks: RVMD (+$52M), UTHR (+$20M), BNTX (+$13M), ABVX (+$11M), CCCC (+$7.5M), IVA (+$7.4M), PHVS (+$6.2M), RCUS, FTH, MIRM.
- Started 6 new stock positions in UTHR, IVA, CCCC, BNTX, FTH, RVMD.
- Reduced shares in these 10 stocks: INSM (-$26M), LEGN (-$18M), NKTR (-$15M), ARGX (-$13M), CELC (-$11M), , CATX (-$6.8M), COGT (-$6.6M), DFTX (-$6.3M), KYMR (-$6.0M).
- Sold out of its positions in SYRE, ASMB, CELC, CTMX, DFTX, HROW, INSM, CATX, LEGN, MRK. NKTR, TARA.
- Patient Square Capital was a net seller of stock by $-5.0M.
- Patient Square Capital has $646M in assets under management (AUM), dropping by 14.53%.
- Central Index Key (CIK): 0001819257
Tip: Access up to 7 years of quarterly data
Positions held by Patient Square Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Patient Square Capital
Patient Square Capital holds 23 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Roivant Sciences SHS (ROIV) | 44.0 | $284M | 8.0M | 35.39 |
|
|
| Revolution Medicines (RVMD) | 8.0 | $52M | NEW | 276k | 187.28 |
|
| Mirum Pharmaceuticals (MIRM) | 4.7 | $31M | +13% | 261k | 117.07 |
|
| Abivax Sa Sponsored Ads (ABVX) | 4.3 | $28M | +70% | 207k | 133.26 |
|
| Beone Medicines Sponsored Ads (ONC) | 4.0 | $26M | +11% | 90k | 284.97 |
|
| Pharvaris N V (PHVS) | 3.6 | $23M | +36% | 671k | 34.58 |
|
| Argenx Se Sponsored Adr (ARGX) | 3.3 | $21M | -37% | 23k | 927.77 |
|
| United Therapeutics Corporation (UTHR) | 3.1 | $20M | NEW | 37k | 541.83 |
|
| Belite Bio Sponsored Ads (BLTE) | 2.6 | $17M | -5% | 110k | 153.99 |
|
| Cogent Biosciences (COGT) | 2.5 | $16M | -28% | 425k | 38.70 |
|
| Dbv Technologies S A Sponsored Ads (DBVT) | 2.3 | $15M | +31% | 910k | 16.40 |
|
| Xenon Pharmaceuticals (XENE) | 2.1 | $13M | -3% | 220k | 60.36 |
|
| Biontech Se Sponsored Ads (BNTX) | 1.9 | $13M | NEW | 134k | 93.05 |
|
| Arcus Biosciences Incorporated (RCUS) | 1.7 | $11M | +82% | 356k | 30.83 |
|
| Enliven Therapeutics (ELVN) | 1.7 | $11M | +6% | 213k | 50.75 |
|
| Dianthus Therapeutics (DNTH) | 1.6 | $11M | +15% | 108k | 97.48 |
|
| Allogene Therapeutics (ALLO) | 1.6 | $11M | +46% | 5.1M | 2.08 |
|
| Eyepoint Com New (EYPT) | 1.6 | $10M | -9% | 720k | 14.30 |
|
| Arcutis Biotherapeutics (ARQT) | 1.5 | $9.7M | -7% | 370k | 26.22 |
|
| C4 Therapeutics Com Stk (CCCC) | 1.2 | $7.5M | NEW | 1.6M | 4.67 |
|
| Inventiva Sa Ads (IVA) | 1.2 | $7.4M | NEW | 2.0M | 3.78 |
|
| Kymera Therapeutics (KYMR) | 0.8 | $5.4M | -52% | 48k | 114.67 |
|
| Faeth Therapeutics Com New (FTH) | 0.7 | $4.4M | NEW | 175k | 25.00 |
|
Past Filings by Patient Square Capital
SEC 13F filings are viewable for Patient Square Capital going back to 2022
- Patient Square Capital 2026 Q2 filed Aug. 12, 2026
- Patient Square Capital 2026 Q1 filed May 15, 2026
- Patient Square Capital 2025 Q4 filed Feb. 12, 2026
- Patient Square Capital 2025 Q3 filed Nov. 10, 2025
- Patient Square Capital 2025 Q2 filed Aug. 11, 2025
- Patient Square Capital 2025 Q1 filed May 14, 2025
- Patient Square Capital 2024 Q4 filed Feb. 14, 2025
- Patient Square Capital 2024 Q3 filed Nov. 14, 2024
- Patient Square Capital 2024 Q1 filed May 14, 2024
- Patient Square Capital 2023 Q4 filed Feb. 13, 2024
- Patient Square Capital 2023 Q3 filed Nov. 14, 2023
- Patient Square Capital 2023 Q2 filed Aug. 11, 2023
- Patient Square Capital 2023 Q1 filed May 10, 2023
- Patient Square Capital 2022 Q4 filed Feb. 13, 2023